Why is personalized medicine important for CLL?
MOR208: an effective drug for the treatment of CLL
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?
Overview of the CLL2-BIG trial of ibrutinib and obinutuzumab
Julia von Tresckow
What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?